Marras C, Beck J, Bower J, Roberts E, Ritz B, Ross G, Abbott R, Savica R, Van Den Eeden S, Willis A (2018) Prevalence of Parkinson’s disease across North America. NPJ Parkinson’s disease 4(1):21

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vacca VM Jr (2019) Parkinson disease: Enhance nursing knowledge. Nursing 2022 49(11):24–32

Google Scholar 

Alissa M, Lones MA, Cosgrove J, Alty JE, Jamieson S, Smith SL, Vallejo M (2022) Parkinson’s disease diagnosis using convolutional neural networks and figure-copying tasks. Neural Comput Appl1–21

Bloem BR, Okun MS, Klein C (2021) Parkinson’s disease. The Lancet 397(10291):2284–2303

Article  CAS  Google Scholar 

Maiti P, Manna J, Dunbar GL (2017) Current understanding of the molecular mechanisms in Parkinson’s disease: Targets for potential treatments. Transl Neurodegener 6:1–35

Article  Google Scholar 

Solari N, Bonito-Oliva A, Fisone G, Brambilla R (2013) Understanding cognitive deficits in Parkinson’s disease: lessons from preclinical animal models. Learn Mem 20(10):592–600

Article  PubMed  Google Scholar 

Dauer W, Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39(6):889–909

Article  CAS  PubMed  Google Scholar 

Alexander GE (2004) Biology of Parkinson’s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci 6(3):259–280

Article  PubMed  PubMed Central  Google Scholar 

Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90(4):675–691

Article  CAS  PubMed  Google Scholar 

Martin I, Dawson VL, Dawson TM (2011) Recent advances in the genetics of Parkinson’s disease. Annu Rev Genomics Hum Genet 12:301–325

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chauhan A, Jeans AF (2015) Is Parkinson’s disease truly a prion-like disorder? An appraisal of current evidence. Neurol Res Int 2015

Davie CA (2008) A review of Parkinson’s disease. Br Med Bull 86(1):109–127

Article  CAS  PubMed  Google Scholar 

Chahine LM, Stern MB (2014) Characterizing premotor Parkinson’s disease: clinical features and objective markers. Movement Disord Clin Pract 1(4):299–306

Article  Google Scholar 

Sveinbjornsdottir S (2016) The clinical symptoms of Parkinson’s disease. J Neurochem 139:318–324

Article  CAS  PubMed  Google Scholar 

Rana AQ, Ahmed US, Chaudry ZM, Vasan S (2015) Parkinson’s disease: a review of non-motor symptoms. Expert Rev Neurother 15(5):549–562

Article  CAS  PubMed  Google Scholar 

Murley AG, Rowe JB (2018) Neurotransmitter deficits from frontotemporal lobar degeneration. Brain 141(5):1263–1285

Article  PubMed  PubMed Central  Google Scholar 

Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79(4):368–376

Article  CAS  PubMed  Google Scholar 

Santens P, Boon P, Van Roost D, Caemaert J (2003) The pathophysiology of motors symptoms in Parkinson’s disease. Acta Neurol Belg 103(3):129–134

CAS  PubMed  Google Scholar 

Goedert M, Jakes R, Anthony Crowther R, Grazia Spillantini M (2001) Parkinson's disease, dementia with lewy bodies, and multiple system atrophy as α-synucleinopathies. Parkinson's Disease: Methods And Protocols 33–59.

Jellinger KA, Korczyn AD (2018) Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease? BMC Med 16(1):1–16

Article  Google Scholar 

Riederer P, Nagatsu T, Youdim MB, Wulf M, Dijkstra JM, Sian-Huelsmann J (2023) Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease. J Neural Transmission 1–20.

Pan L, Meng L, He M, Zhang Z (2021) Tau in the Pathophysiology of Parkinson’s Disease. J Mol Neurosci 71(11):2179–2191. https://doi.org/10.1007/s12031-020-01776-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Gao F, Wang D, Li C, Fu Y, He W, Zhang J (2018) Tau pathology in Parkinson’s disease. Front Neurol 9:809

Article  PubMed  PubMed Central  Google Scholar 

Trushina NI, Bakota L, Mulkidjanian AY, Brandt R (2019) The evolution of tau phosphorylation and interactions. Front Aging Neurosci 11:256

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deas E, Plun-Favreau H, Wood NW (2009) PINK1 function in health and disease. EMBO Mol Med 1(3):152–165

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferreira M, Massano J (2017) An updated review of Parkinson’s disease genetics and clinicopathological correlations. Acta Neurol Scand 135(3):273–284

Article  CAS  PubMed  Google Scholar 

Seo J-H, Song S-K, Lee PH (2009) A novel PANK2 mutation in a patient with atypical pantothenate-kinase-associated neurodegeneration presenting with adult-onset parkinsonism. J Clin Neurol 5(4):192–194

Article  PubMed  PubMed Central  Google Scholar 

Tseng W-EJ, Chen C-M, Chen Y-C, Yi Z, Tan E-K, Wu Y-R (2013) Genetic variations of GAK in two Chinese Parkinson’s disease populations: a case-control study. PLoS ONE 8(6):e67506

Article  CAS  PubMed  PubMed Central  Google Scholar 

Camargos S, Scholz S, Simón-Sánchez J, Paisán-Ruiz C, Lewis P, Hernandez D, Ding J, Gibbs JR, Cookson MR, Bras J (2008) DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. The Lancet Neurology 7(3):207–215

Article  CAS  PubMed  Google Scholar 

Hiona A, Sanz A, Kujoth GC, Pamplona R, Seo AY, Hofer T, Someya S, Miyakawa T, Nakayama C, Samhan-Arias AK (2010) Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoS ONE 5(7):e11468

Article  PubMed  PubMed Central  Google Scholar 

Ganesan S, Parvathi VD (2021) Deconstructing the molecular genetics behind the PINK1/Parkin axis in Parkinson’s disease using Drosophila melanogaster as a model organism. Egyptian J Med Human Genetics 22(1):86. https://doi.org/10.1186/s43042-021-00208-2

Article  Google Scholar 

Saunders-Pullman R, Raymond D, Elango S (2023) LRRK2 Parkinson disease. GeneReviews®[Internet].

Mata IF, Hutter CM, González-Fernández MC, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C et al (2009) Lrrk2 R1441G-related Parkinson’s disease: evidence of a common founding event in the seventh century in Northern Spain. Neurogenetics 10(4):347–353. https://doi.org/10.1007/s10048-009-0187-z

Article  PubMed  PubMed Central  Google Scholar 

Ryan BJ, Hoek S, Fon EA, Wade-Martins R (2015) Mitochondrial dysfunction and mitophagy in Parkinson’s: from familial to sporadic disease. Trends Biochem Sci 40(4):200–210

Article  CAS  PubMed  Google Scholar 

Li N-N, Chang X-L, Mao X-Y, Zhang J-H, Zhao D-M, Tan E-K, Peng R (2012) GWAS-linked GAK locus in Parkinson’s disease in Han Chinese and meta-analysis. Hum Genet 131(7):1089–1093. https://doi.org/10.1007/s00439-011-1133-3

Article  CAS  PubMed  Google Scholar 

van der Brug MP, Singleton A, Gasser T, Lewis PA (2015) Parkinson’s disease: from human genetics to clinical trials. Sci Transl Med 7(305):305ps320-305ps320

Google Scholar 

Zech M, Castrop F, Schormair B, Jochim A, Wieland T, Gross N, Lichtner P, Peters A, Gieger C, Meitinger T (2014) DYT16 revisited: exome sequencing identifies PRKRA mutations in a European dystonia family. Mov Disord 29(12):1504–1510

Article  CAS  PubMed